Evolus (EOLS) Research & Development (2017 - 2026)

Evolus has reported Research & Development for 10 years, with the latest figure at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 1.27% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 3.2% YoY), and the FY2025 full-year result was $9.6 million, up 4.4% from the prior year.
• Research & Development for Q1 2026 stood at $2.2 million, down from $3.5 million in the prior quarter.
• The five-year high for Research & Development was $3.5 million in Q4 2025, with the low at $468000.0 in Q1 2022.
• Historically, Research & Development has averaged $1.9 million across 5 years, with a median of $2.0 million in 2025.
• The largest YoY upside for Research & Development was 357.14% in 2022 against a maximum downside of 44.35% in 2022.
• Evolus' Research & Development stood at $1.3 million in 2022, then surged by 76.56% to $2.4 million in 2023, then advanced by 2.1% to $2.4 million in 2024, then soared by 43.25% to $3.5 million in 2025, then slumped by 35.65% to $2.2 million in 2026.
• The last three Research & Development figures came in at $2.2 million (Q1 2026), $3.5 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.